Track topics on Twitter Track topics that are important to you
Nordic Nanovector ASA has received feedback from the Regional Committees for Medical and Health Research Ethics (REK) in Norway with regard to the Clinical Trial Application (CTA) for the Archer─1 phase 1b trial with Betalutin
Original Article: Nordic updates on CTA for Archer─1 and PARADIGME trials in NorwayNEXT ARTICLE
Bioethics is the study of controversial ethics brought about by advances in biology and medicine. Bioethicists are concerned with the ethical questions that arise in the relationships among life sciences, biotechnology, medicine, politics, law, and philo...
In a clinical trial or interventional study, participants receive specific interventions according to the research plan or protocol created by the investigators. These interventions may be medical products, such as drugs or devices; procedures; or change...